Quality of Life in Patients With Bladder Cancer

Active, not recruiting

• Conditions: Bladder Cancer
• Interventions: Behavioral: Quality Of Life questionnaires

• Registration Number: NCT00745355
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to learn about the quality of life of people living with bladder cancer. We are interested in learning about how the treatments for bladder cancer affect people. We plan to use the findings from this study to help doctors provide better care and information to patients with bladder cancer.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-08
• Study First Submitted: 2008-08-22
• Study First Submitted QC: 2008-09-02
• Study First Posted: 2008-09-03
• Status Verified: 2024-05
• Last Update Submitted: 2024-05-28
• Last Update Posted: 2024-05-29
• Primary Completion: 2026-08
• Study Completion: 2026-08

Recruitment & Eligibility

• Status: ACTIVE_NOT_RECRUITING
• Sex: All
• Target Recruitment: 550

Inclusion Criteria

• All patients (male and female) who are diagnosed with bladder cancer
• Patients must be scheduled for radical cystectomy and urinary diversion are and/or being evaluated for neo-adjuvant chemotherapy prior to a planned cystectomy.
• Participants must be able to speak English.
• Participants must be able to provide informed consent.
• Participants must be 18 years of age or older to enroll.
• Participant may be eligible for and may receive neoadjuvant or adjuvant chemotherapy.
• Participant may have had intravesicle chemotherapy or immunotherapy (BCG, Interferon).

Read More

Exclusion Criteria

• Subjects may be excluded from the study based on the following criteria:
• Follow-up care not obtained at MSKCC.
• Metastatic disease at diagnosis.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
1	Quality Of Life questionnaires	new patients with bladder cancer and/or are scheduled for radical cystectomy and urinary diversion

Primary Outcome Measures

Name	Time	Method
Prospectively characterize the impact of radical cystectomy and different urinary diversions on quality of life of bladder cancer patients.	conclusion of study

Secondary Outcome Measures

Name	Time	Method
Compare various standard and idiographic measures of QOL, to determine their relative contributions in accounting for variance in key outcome criteria and prediction of patient QOL at subsequent assessment points.	conclusion of study
Examine how patients react to more in-depth probing of the interview associated with idiographic assessment.	conclusion of study
Develop a predictive model of QOL after radical cystectomy & urinary diversion using the data from idiographic and standard QOL measures. This model can ultimately be used in office based practice to guide treatment planning with each patient.	conclusion of study

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center; 🇺🇸 New York, New York, United States